BDTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.97%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $11,973,484.44

Black Diamond Therapeutics Insider Trading History Chart

Black Diamond Therapeutics Share Price & Price History

^$2.43

▲ +0.06 (2.53%)

As of 06/12/2025 05:00 PM ET

Days: 30 | 90 | 365

Black Diamond Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/19/2025	Growth N V Biotech	Major Shareholder	Sell	5,784,292	$2.07	$11,973,484.44	2,733,547
10/17/2023	Growth N V Biotech	Major Shareholder	Buy	400,000	$2.34	$936,000.00	8,517,839
7/5/2023	Ali Behbahani	Director	Buy	1,000,000	$5.00	$5,000,000.00	4,448,757
6/30/2023	Growth N V Biotech	Major Shareholder	Buy	1,000,000	$5.00	$5,000,000.00	8,117,839
6/27/2023	David M Epstein	Insider	Sell	25,000	$6.70	$167,500.00	671,423
6/27/2023	Growth N V Biotech	Major Shareholder	Buy	1,740,000	$5.49	$9,552,600.00	7,117,839
10/27/2022	Growth N V Biotech	Major Shareholder	Buy	191,678	$1.87	$358,437.86	5,105,064
10/21/2022	Growth N V Biotech	Major Shareholder	Buy	87,850	$1.51	$132,653.50	4,913,386
10/19/2022	Growth N V Biotech	Major Shareholder	Buy	77,689	$1.32	$102,549.48	4,771,802
6/29/2022	Fang Ni	Insider	Buy	25,000	$2.44	$61,000.00	69,026

SEC Filings (Institutional Ownership Changes) for Black Diamond Therapeutics (NASDAQ:BDTX)

95.47% of Black Diamond Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Black Diamond Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2025	AQR Capital Management LLC	54,122	$84K	0.0%	N/A	0.095%
5/16/2025	AWM Investment Company Inc.	500,000	$0.78M	0.1%	N/A	0.882%
5/14/2025	Affinity Asset Advisors LLC	250,000	$0.39M	0.0%	-55.3%	0.441%
5/14/2025	T. Rowe Price Investment Management Inc.	10,399,241	$16.12M	0.0%	-0.6%	18.348%
5/12/2025	Invesco Ltd.	45,989	$71K	0.0%	+152.5%	0.081%
5/8/2025	XTX Topco Ltd	42,198	$65K	0.0%	-54.1%	0.074%
5/7/2025	Brown Wealth Management LLC	100,000	$0.16M	0.1%	N/A	0.176%
3/24/2025	Wellington Management Group LLP	221,236	$0.47M	0.0%	+7.9%	0.390%
2/17/2025	Vestal Point Capital LP	5,600,000	$11.98M	0.7%	+11.4%	9.897%
2/17/2025	Squarepoint Ops LLC	131,874	$0.28M	0.0%	+122.8%	0.233%
2/17/2025	Tang Capital Management LLC	2,070,209	$4.43M	0.3%	+51.1%	3.659%
2/17/2025	Nuveen Asset Management LLC	201,535	$0.43M	0.0%	+12.8%	0.356%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	104,560	$0.22M	0.0%	-73.2%	0.185%
2/17/2025	Millennium Management LLC	558,076	$1.19M	0.0%	+503.0%	0.986%
2/17/2025	D. E. Shaw & Co. Inc.	17,317	$37K	0.0%	N/A	0.031%
2/17/2025	DAFNA Capital Management LLC	140,000	$0.30M	0.1%	+12.0%	0.247%
2/17/2025	Cubist Systematic Strategies LLC	53,383	$0.11M	0.0%	N/A	0.094%
2/17/2025	Bridgeway Capital Management LLC	144,600	$0.31M	0.0%	-3.1%	0.256%
2/17/2025	Bank of America Corp DE	74,719	$0.16M	0.0%	+76.7%	0.132%
2/14/2025	Boxer Capital Management LLC	506,000	$1.08M	0.1%	N/A	0.894%
2/14/2025	Northern Trust Corp	382,747	$0.82M	0.0%	+10.9%	0.676%
2/14/2025	Susquehanna Fundamental Investments LLC	74,903	$0.16M	0.0%	N/A	0.132%
2/14/2025	Price T Rowe Associates Inc. MD	14,182	$31K	0.0%	-96.3%	0.025%
2/14/2025	T. Rowe Price Investment Management Inc.	10,466,721	$22.40M	0.0%	-2.5%	18.499%
2/14/2025	Hsbc Holdings PLC	27,159	$59K	0.0%	+99.0%	0.048%
2/14/2025	Stifel Financial Corp	166,000	$0.36M	0.0%	+10.4%	0.293%
2/14/2025	Dimensional Fund Advisors LP	661,436	$1.42M	0.0%	+158.5%	1.169%
2/13/2025	Affinity Asset Advisors LLC	559,163	$1.20M	0.2%	N/A	0.988%
2/13/2025	Walleye Capital LLC	68,016	$0.15M	0.0%	+507.6%	0.120%
2/13/2025	XTX Topco Ltd	91,922	$0.20M	0.0%	N/A	0.162%
2/13/2025	Barclays PLC	86,545	$0.19M	0.0%	+10.7%	0.153%
2/13/2025	Kennedy Capital Management LLC	433,793	$0.93M	0.0%	-34.0%	0.767%
2/13/2025	Raymond James Financial Inc.	24,992	$53K	0.0%	N/A	0.044%
2/13/2025	Renaissance Technologies LLC	904,000	$1.94M	0.0%	+256.2%	1.598%
2/13/2025	Wells Fargo & Company MN	20,119	$43K	0.0%	+41.8%	0.036%
2/12/2025	Geode Capital Management LLC	959,316	$2.05M	0.0%	+1.5%	1.696%
2/12/2025	Wellington Management Group LLP	221,236	$0.47M	0.0%	+7.9%	0.391%
2/12/2025	JPMorgan Chase & Co.	18,929	$41K	0.0%	+429.6%	0.033%
2/11/2025	Sei Investments Co.	22,802	$49K	0.0%	N/A	0.040%
2/11/2025	Intech Investment Management LLC	19,247	$41K	0.0%	+49.1%	0.034%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	246,681	$0.53M	0.0%	-13.2%	0.436%
2/7/2025	SLT Holdings LLC	31,000	$66K	0.1%	N/A	0.055%
2/6/2025	Raymond James Financial Inc.	24,992	$53K	0.0%	N/A	0.044%
2/4/2025	Bank of New York Mellon Corp	207,074	$0.44M	0.0%	+46.1%	0.366%
1/30/2025	Rhumbline Advisers	56,135	$0.12M	0.0%	+14.9%	0.099%
1/22/2025	Foundations Investment Advisors LLC	31,000	$66K	0.0%	-69.7%	0.055%
1/17/2025	SG Americas Securities LLC	19,491	$42K	0.0%	N/A	0.034%
11/19/2024	Barclays PLC	78,151	$0.34M	0.0%	+201.9%	0.138%
11/16/2024	Geode Capital Management LLC	944,877	$4.11M	0.0%	+12.2%	1.670%
11/15/2024	Barclays PLC	78,151	$0.34M	0.0%	+201.9%	0.138%
11/15/2024	Wellington Management Group LLP	204,957	$0.89M	0.0%	+12.8%	0.362%
11/15/2024	State Street Corp	809,196	$3.52M	0.0%	+17.2%	1.430%
11/15/2024	Point72 Asset Management L.P.	697,125	$3.03M	0.0%	N/A	1.232%
11/14/2024	Vestal Point Capital LP	5,028,500	$21.87M	1.7%	+139.5%	8.887%
11/14/2024	Walleye Capital LLC	11,195	$49K	0.0%	N/A	0.020%
11/14/2024	MetLife Investment Management LLC	22,286	$97K	0.0%	+129.1%	0.039%
11/13/2024	FMR LLC	179,068	$0.78M	0.0%	N/A	0.316%
11/12/2024	Charles Schwab Investment Management Inc.	109,224	$0.48M	0.0%	+6.9%	0.193%
11/9/2024	Intech Investment Management LLC	12,907	$56K	0.0%	N/A	0.023%
11/6/2024	Cornercap Investment Counsel Inc.	22,583	$98K	0.0%	-53.1%	0.040%
10/21/2024	Foundations Investment Advisors LLC	102,300	$0.45M	0.0%	-9.9%	0.182%
10/16/2024	Vontobel Holding Ltd.	15,723	$68K	0.0%	N/A	0.028%
8/16/2024	Algert Global LLC	28,501	$0.13M	0.0%	N/A	0.051%
8/15/2024	The Manufacturers Life Insurance Company	60,189	$0.28M	0.0%	N/A	0.107%
8/15/2024	Affinity Asset Advisors LLC	650,000	$3.03M	0.3%	N/A	1.155%
8/14/2024	Squarepoint Ops LLC	25,351	$0.12M	0.0%	-85.2%	0.045%
8/14/2024	Marshall Wace LLP	94,537	$0.44M	0.0%	N/A	0.168%
8/14/2024	Ally Bridge Group NY LLC	835,000	$3.89M	2.3%	N/A	1.484%
8/12/2024	Marathon Trading Investment Management LLC	19,116	$89K	0.0%	-79.8%	0.034%
8/9/2024	Renaissance Technologies LLC	263,900	$1.23M	0.0%	+24.1%	0.469%
8/9/2024	Dimensional Fund Advisors LP	200,044	$0.93M	0.0%	+79.1%	0.356%
8/3/2024	TD Asset Management Inc	266,312	$1.24M	0.0%	+275.9%	0.473%
8/2/2024	Foundations Investment Advisors LLC	113,550	$0.53M	0.0%	+17.7%	0.202%
8/1/2024	Rhumbline Advisers	46,850	$0.22M	0.0%	+10,334.3%	0.083%
7/26/2024	Bank of New York Mellon Corp	108,959	$0.51M	0.0%	N/A	0.194%
7/12/2024	SG Americas Securities LLC	23,146	$0.11M	0.0%	N/A	0.041%
5/17/2024	Artal Group S.A.	1,046,517	$5.31M	0.1%	-48.9%	1.860%
5/16/2024	Kennedy Capital Management LLC	717,183	$3.64M	0.1%	-3.2%	1.275%
5/15/2024	Bellevue Group AG	8,517,839	$43.19M	0.7%	-0.2%	15.142%
5/10/2024	Acadian Asset Management LLC	170,510	$0.86M	0.0%	+13.8%	0.325%
5/10/2024	Vanguard Group Inc.	1,905,300	$9.66M	0.0%	-2.1%	3.627%
5/7/2024	Susquehanna Fundamental Investments LLC	16,218	$82K	0.0%	N/A	0.031%
2/14/2024	Bellevue Group AG	8,535,839	$23.99M	0.4%	+4.9%	16.533%
2/14/2024	Pale Fire Capital SE	51,100	$0.14M	0.0%	N/A	0.099%
2/7/2024	Jump Financial LLC	38,888	$0.11M	0.0%	+245.0%	0.075%
1/30/2024	Cornercap Investment Counsel Inc.	82,784	$0.23M	0.0%	N/A	0.160%
12/6/2023	Citigroup Inc.	61,348	$0.18M	0.0%	N/A	0.119%
11/14/2023	Newtyn Management LLC	205,000	$0.59M	0.1%	+2.5%	0.397%
11/14/2023	Deerfield Management Company L.P. Series C	930,447	$2.67M	0.1%	-48.3%	1.802%
11/13/2023	CHI Advisors LLC	720,000	$2.07M	0.6%	-4.0%	1.395%
11/13/2023	Algert Global LLC	19,820	$57K	0.0%	N/A	0.038%
11/7/2023	Barclays PLC	322,246	$0.93M	0.0%	+159.1%	0.625%
11/7/2023	Jump Financial LLC	11,272	$32K	0.0%	N/A	0.022%
8/22/2023	CHI Advisors LLC	750,000	$3.79M	1.1%	N/A	2.054%
8/15/2023	RA Capital Management L.P.	3,525,754	$17.81M	0.3%	+36.1%	9.657%
8/14/2023	Bellevue Group AG	8,135,839	$41.09M	0.6%	+50.8%	22.282%
8/14/2023	Rock Springs Capital Management LP	563,233	$2.84M	0.1%	N/A	1.543%
8/14/2023	Driehaus Capital Management LLC	696,969	$3.52M	0.0%	N/A	1.909%
8/11/2023	VR Adviser LLC	353,629	$1.79M	0.3%	N/A	0.969%
8/11/2023	Artal Group S.A.	2,046,517	$10.34M	0.3%	+24.3%	5.605%

Data available starting January 2016

Black Diamond Therapeutics, Inc., a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is BDTX-1535, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as phase 1 clinical trial to treat glioblastoma. It is also developing BDTX-4933, a brain-penetrant RAF MasterKey inhibitor targeting KRAS, NRAS, and BRAF alterations in solid tumors that is in phase 1 clinical trial. In addition, the company is developing BDTX-4876, a MasterKey inhibitor of oncogenic FGFR2/3 mutations with selectivity versus FGFR1/4, which is in preclinical stage. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $2.43

$2.30

$2.45

50 Day Range

MA: $1.82

$1.25

$2.58

52 Week Range

Now: $2.43

$1.20

$6.75

Volume

1,082,023 shs

Average Volume

1,528,911 shs

Market Capitalization

$138.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.71

Who are the company insiders with the largest holdings of Black Diamond Therapeutics?: Black Diamond Therapeutics' top insider shareholders include:
Growth N V Biotech (Major Shareholder)
Ali Behbahani (Director)
David M Epstein (Insider)
Learn More about top insider investors at Black Diamond Therapeutics.
Who are the major institutional investors of Black Diamond Therapeutics?: Black Diamond Therapeutics' top institutional shareholders include:
T. Rowe Price Investment Management Inc. — 18.35%
AWM Investment Company Inc. — 0.88%
Affinity Asset Advisors LLC — 0.44%
Brown Wealth Management LLC — 0.18%
AQR Capital Management LLC — 0.10%
Invesco Ltd. — 0.08%
Learn More about top institutional investors of Black Diamond Therapeutics stock.
Which major investors are selling Black Diamond Therapeutics stock?: During the last quarter, BDTX stock was sold by these institutional investors:
Affinity Asset Advisors LLC
T. Rowe Price Investment Management Inc.
XTX Topco Ltd
Simplex Trading LLC
Which major investors are buying Black Diamond Therapeutics stock?: In the previous quarter, BDTX stock was purchased by institutional investors including:
AWM Investment Company Inc.
Brown Wealth Management LLC
AQR Capital Management LLC
Invesco Ltd.
In the last year, these company insiders have bought Black Diamond Therapeutics stock:
Growth N V Biotech (Major Shareholder)
Ali Behbahani (Director)
Learn More investors buying Black Diamond Therapeutics stock.